CVE-2023-22868

🗓️ 17 Feb 2023 17:11:15Reported by ibmType

IBM Aspera Faspex 4.4.1 cross-site scripting vulnerabilit

AI Insights are available for you today

Leverage the power of AI to quickly understand vulnerabilities, impacts, and exploitability

Reporter	Title	Published	Views	Family All 7
CNVD	IBM Aspera Faspex Cross-Site Scripting Vulnerability	21 Feb 202300:00	–	cnvd
Cvelist	CVE-2023-22868 IBM Aspera Faspex cross-site scripting	17 Feb 202316:01	–	cvelist
NVD	CVE-2023-22868	17 Feb 202317:15	–	nvd
Prion	Cross site scripting	17 Feb 202317:15	–	prion
Vulnrichment	CVE-2023-22868 IBM Aspera Faspex cross-site scripting	17 Feb 202316:01	–	vulnrichment
Tenable Nessus	IBM Aspera Faspex < 4.4.2 Patch Level 2 Multiple Vulnerabilities	20 Mar 202300:00	–	nessus
IBM Security Bulletins	Security Bulletin: IBM Aspera Faspex 4.4.2 PL2 has addressed multiple vulnerabilities (CVE-2022-28330, CVE-2023-22868, CVE-2022-30556, CVE-2022-31813, CVE-2022-30522, CVE-2022-47986, CVE-2022-28615, CVE-2022-26377, CVE-2018-25032, CVE-2022-2068)	12 Nov 202402:31	–	ibm

Nvd

Vulners

Node

ibm aspera_faspexRange≤4.4.1

ibm aspera_faspexMatch4.4.1patch_level_1

AND

linux linux_kernelMatch-

microsoft windowsMatch-

[
  {
    "defaultStatus": "unaffected",
    "product": "Aspera Faspex",
    "vendor": "IBM",
    "versions": [
      {
        "status": "affected",
        "version": "4.4.1"
      }
    ]
  }
]

Source	Link
exchange	www.exchange.xforce.ibmcloud.com/vulnerabilities/244117
ibm	www.ibm.com/support/pages/node/6952319

Transform Your Security Services

Elevate your offerings with Vulners' advanced Vulnerability Intelligence. Contact us for a demo and discover the difference comprehensive, actionable intelligence can make in your security strategy.

Book a live demo

17 Feb 2023 17:15Current

5.2Medium risk

Vulners AI Score5.2

CVSS35.4

EPSS0.00187

SSVC

CWE-79